Kai Schulze Department of Vaccinology and Applied Microbiology Helmholtz Centre for Infection Research Biography Publications Institution JoVE Articles Kai Schulze has not added a biography. If you are Kai Schulze and would like to personalize this page please email our Author Liaison for assistance. Publications Mucosal Administration of Cycle-Di-Nucleotide-Adjuvanted Virosomes Efficiently Induces Protection Against Influenza H5N1 in Mice Frontiers in Immunology. 2017 | Pubmed ID: 29033942 Self-replicating RNA Vaccine Functionality Modulated by Fine-tuning of Polyplex Delivery Vehicle Structure Journal of Controlled Release : Official Journal of the Controlled Release Society. Nov, 2017 | Pubmed ID: 28935594 Bivalent Mucosal Peptide Vaccines Administered Using the LCP Carrier System Stimulate Protective Immune Responses Against Streptococcus Pyogenes Infection Nanomedicine : Nanotechnology, Biology, and Medicine. Nov, 2017 | Pubmed ID: 28887213 Type I IFN and Not TNF, is Essential for Cyclic Di-nucleotide-elicited CTL by a Cytosolic Cross-presentation Pathway EBioMedicine. Aug, 2017 | Pubmed ID: 28754303 Role of Autophagy in HIV-1 Matrix Protein P17-Driven Lymphangiogenesis Journal of Virology. 08, 2017 | Pubmed ID: 28592537 Immunization with Tc52 or Its Amino Terminal Domain Adjuvanted with C-di-AMP Induces Th17+Th1 Specific Immune Responses and Confers Protection Against Trypanosoma Cruzi PLoS Neglected Tropical Diseases. Feb, 2017 | Pubmed ID: 28234897 New Horizons in the Development of Novel Needle-Free Immunization Strategies to Increase Vaccination Efficacy Current Topics in Microbiology and Immunology. 2016 | Pubmed ID: 27370343 Generation of HLA-universal IPSCs-derived Megakaryocytes and Platelets for Survival Under Refractoriness Conditions Molecular Medicine (Cambridge, Mass.). May, 2016 | Pubmed ID: 27262025 Modeling Influenza Virus Infection: A Roadmap for Influenza Research Viruses. Oct, 2015 | Pubmed ID: 26473911 Rodents As Pre-clinical Models for Predicting Vaccine Performance in Humans Expert Review of Vaccines. 2015 | Pubmed ID: 26268433 Inverse Micellar Sugar Glass (IMSG) Nanoparticles for Transfollicular Vaccination Journal of Controlled Release : Official Journal of the Controlled Release Society. May, 2015 | Pubmed ID: 25795506 Efficient Nanoparticle-mediated Needle-free Transcutaneous Vaccination Via Hair Follicles Requires Adjuvantation Nanomedicine : Nanotechnology, Biology, and Medicine. Jan, 2015 | Pubmed ID: 25200611 Intranasal Delivery of Influenza RNP Adjuvanted with C-di-AMP Induces Strong Humoral and Cellular Immune Responses and Provides Protection Against Virus Challenge PloS One. 2014 | Pubmed ID: 25140692 Vaccine Adjuvants: Key Tools for Innovative Vaccine Design Current Topics in Medicinal Chemistry. 2013 | Pubmed ID: 24066891 Development and Characterization of Attenuated Metabolic Mutants of Bordetella Bronchiseptica for Applications in Vaccinology Environmental Microbiology. Jan, 2013 | Pubmed ID: 22676396 Bis-(3',5')-cyclic Dimeric Adenosine Monophosphate: Strong Th1/Th2/Th17 Promoting Mucosal Adjuvant Vaccine. Jul, 2011 | Pubmed ID: 21619907 The FAI Protein of Group C Streptococci Acts As a Mucosal Adjuvant by the Specific Targeting and Activation of B Cells International Journal of Medical Microbiology : IJMM. Jan, 2008 | Pubmed ID: 17884726 A Pegylated Derivative of Alpha-galactosylceramide Exhibits Improved Biological Properties Journal of Immunology (Baltimore, Md. : 1950). Aug, 2007 | Pubmed ID: 17675464 The Bacterial Second Messenger CdiGMP Exhibits Promising Activity As a Mucosal Adjuvant Clinical and Vaccine Immunology : CVI. Aug, 2007 | Pubmed ID: 17567766 The Bacterial Second Messenger Cyclic DiGMP Exhibits Potent Adjuvant Properties Vaccine. Feb, 2007 | Pubmed ID: 17187906 Snabb In Vivo bedömning av adjuvants cytotoxiska T-lymfocyter generations möjligheter för utveckling av vaccin Darío Lirussi1, Thomas Ebensen1, Kai Schulze1, Elena Reinhard1, Stephanie Trittel1, Peggy Riese1, Blair Prochnow1, Carlos A. Guzmán1 1Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research JoVE 57401 Medicine
Snabb In Vivo bedömning av adjuvants cytotoxiska T-lymfocyter generations möjligheter för utveckling av vaccin Darío Lirussi1, Thomas Ebensen1, Kai Schulze1, Elena Reinhard1, Stephanie Trittel1, Peggy Riese1, Blair Prochnow1, Carlos A. Guzmán1 1Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research JoVE 57401 Medicine